NDC 51437-202 - Medicated Anti-Itch
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51437-202
- Package NDCs from labels
- 51437-202-08
- Manufacturer
- Nootie, LLC
- Effective date
- 2016-08-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Medicated Anti-Itch - Nootie, LLC | Nootie, LLC | 2016-08-16 | OTC ANIMAL DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pramoxine Hydrochloride Anorectal | PRAMOXINE HYDROCHLORIDE | Stratus Pharmaceuticals | 39a16b66-b0e9-412f-8773-8dec0a1227e0 | 2025-10-02 | Warnings | 88AYB867L5 |
| PROSTAT FIRST AID Burn Ease, 0.9g | LIDOCAINE | ProStat First Aid LLC | dc704403-e2aa-47f7-a7f4-f6afe1547ca8 | 2025-10-01 | Warnings | V13007Z41A |
| PROSTAT FIRST AID Burn Ease, 0.9g | LIDOCAINE | ProStat First Aid LLC | e02558a9-fe2b-4f28-9fd3-7308f859d759 | 2025-10-01 | Warnings | V13007Z41A |
| FL Burn Ease, 0.9g | LIDOCAINE | ProStat First Aid LLC | 4dc0d579-ab42-4ea5-9788-5e54d7d318a3 | 2025-10-01 | Warnings | V13007Z41A |
| Lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Atlantic Biologicals Corp. | 401ecb6c-392b-1d74-e063-6294a90a4005 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | V13007Z41A |
| Xpect First Aid Cream | BENZALKONIUM CHLORIDE, LIDOCAINE HCL | Cintas Corporation | f7112e5d-c8c4-42ad-8a65-24bfc32d4aea | 2025-09-30 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | bb53bb10-bb36-4c9b-b632-71455615f9f3 | 2025-09-29 | Warnings, Adverse reactions | V13007Z41A |
| LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | Henry Schein, Inc. | ee21518e-b3ed-405a-ac3b-bfe753893dba | 2025-09-29 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE ANHYDROUS | Henry Schein, Inc. | a5d4b206-cc53-470f-9bca-abfc6ea5cc99 | 2025-09-29 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE | Henry Schein, Inc. | 0c0790ec-effd-4d8a-9874-8ca0b31e54d0 | 2025-09-29 | Warnings, Adverse reactions | V13007Z41A |
| UniShield First Aid Burn | LIDOCAINE HCL | Unishield | f729c557-da4b-3fb5-e053-6394a90a4196 | 2025-09-28 | Warnings | V13007Z41A |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE PRAMOXINE HCL | Encube Ethicals, Inc. | dfea6b2e-cd76-439d-a3da-64e2d8717163 | 2025-09-25 | Warnings | 88AYB867L5 |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF CREAM | Neilmed Pharmaceuticals Inc. | 374dc1c0-4243-b272-e063-6394a90a5a6b | 2025-09-24 | Warnings | 88AYB867L5 |
| Xpect Burn Care | BURN CARE | Cintas Corp | 3665eb99-9602-4949-8af4-3ce7ed24303c | 2025-09-23 | Warnings | V13007Z41A |
| Lidocaine 5% Gel | LIDOCAINE HCL 5% | Puretek Corporation | 3f2f0f2b-2759-c010-e063-6394a90a8e5e | 2025-09-19 | Warnings, Adverse reactions | V13007Z41A |
| InkKulture Numbing | LIDOCAINE HCL | Prodigy Media Inc | 85a64315-dfa5-4f23-9f61-1cce694ea6bd | 2025-09-17 | Warnings | V13007Z41A |
| Ink Scribd Numbing | LIDOCAINE HCL | Prodigy Media Inc | 54173858-aff0-43b2-bc7b-c4ecab9bc3e5 | 2025-09-17 | Warnings | V13007Z41A |
| Inkorporated Numbing | LIDOCAINE HCL | Prodigy Media Inc | 3017056c-f3c6-4300-8344-bf6e7d32e870 | 2025-09-17 | Warnings | V13007Z41A |
| TattooGirl Numbing | LIDOCAINE HCL | Prodigy Media Inc | 6abe4540-f6c9-412a-83f3-682df7715057 | 2025-09-17 | Warnings | V13007Z41A |
| Dr Tatty Numbing | LIDOCAINE HCL | Prodigy Media Inc | 5bb558c1-bf8f-4956-8732-e19720f62f31 | 2025-09-17 | Warnings | V13007Z41A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.